首站-论文投稿智能助手
典型文献
Microwave ablation vs. surgical resection for treatment na?ve hepatocellular carcinoma within the Milan criteria: a follow-up of at least 5 years
文献摘要:
Objective: Thermal ablation poses challenges in the surgical resection (SR) of small hepatocellular carcinoma (HCC), and its therapeutic outcomes for larger lesions remain debated.Methods: This retrospective study evaluated 729 patients with HCC meeting the Milan criteria, who were treated with curative SR or microwave ablation (MWA) between 2008 and 2014. Overall survival (OS), cancer-specific survival (CSS), disease-free survival (DFS), and local tumor progression (LTP) were compared after propensity score matching (PSM). Co-variates associated with OS, CSS, LTP, and DFS were identified. The risk of death and tumor progression were compared. Results: During the median follow-up of 78.6 months, 253 patients were included in each group after PSM. For tumors ≤ 3.0 cm and 3.1–4.0 cm, MWA achieved comparable results in terms of OS, CSS, DFS, and LTP. For tumors 4.1–5.0 cm, MWA had lower OS, CSS, and DFS rates (all P < 0.05) than SR. Higher LTP rates were observed in the MWA group for tumors 4.1–5.0 cm, although the difference was not significant (P = 0.18). Complication rates (P = 0.41) were similar, but MWA led to less estimated blood loss (P < 0.01) and shorter postoperative hospitalization times (P < 0.01). Conclusions: MWA achieved comparable long-term oncologic outcomes with SR for ≤ 4 cm HCC, with lower complication rates and faster recovery.
文献关键词:
作者姓名:
Jianping Dou;Zhigang Cheng;Zhiyu Han;Fangyi Liu;Zhen Wang;Xiaoling Yu;Jie Yu;Ping Liang
作者机构:
Department of Interventional Ultrasound,Chinese PLA General Hospital,Beijing 100853,China
引用格式:
[1]Jianping Dou;Zhigang Cheng;Zhiyu Han;Fangyi Liu;Zhen Wang;Xiaoling Yu;Jie Yu;Ping Liang-.Microwave ablation vs. surgical resection for treatment na?ve hepatocellular carcinoma within the Milan criteria: a follow-up of at least 5 years)[J].癌症生物学与医学(英文版),2022(07):1078-1088
A类:
B类:
Microwave,ablation,surgical,resection,treatment,na,hepatocellular,carcinoma,within,Milan,criteria,follow,least,years,Objective,Thermal,poses,challenges,SR,small,HCC,its,therapeutic,outcomes,larger,lesions,remain,debated,Methods,This,retrospective,study,evaluated,patients,meeting,who,were,treated,curative,microwave,MWA,between,Overall,survival,OS,cancer,specific,CSS,disease,free,DFS,local,progression,LTP,compared,after,propensity,score,matching,PSM,variates,associated,identified,risk,death,Results,During,median,months,included,each,group,For,tumors,achieved,comparable,results,terms,had,lower,rates,than,Higher,observed,although,difference,was,not,significant,Complication,similar,but,led,less,estimated,blood,loss,shorter,postoperative,hospitalization,times,Conclusions,long,oncologic,complication,faster,recovery
AB值:
0.569342
相似文献
CT-based radiomics to predict development of macrovascular invasion in hepatocellular carcinoma:A multicenter study
Jing-Wei Wei;Si-Rui Fu;Jie Zhang;Dong-Sheng Gu;Xiao-Qun Li;Xu-Dong Chen;Shuai-Tong Zhang;Xiao-Fei He;Jian-Feng Yan;Li-Gong Lu;Jie Tian-Key Laboratory of Molecular Imaging,Institute of Automation,Chinese Academy of Sciences,Beijing 100190,China;Beijing Key Laboratory of Molecular Imaging,Beijing 100190,China;University of Chinese Academy of Sciences,Beijing 100049,China;Zhuhai Interventional Medical Center,Zhuhai Precision Medical Center,Zhuhai People's Hospital,Zhuhai Hospital of Jinan University,Zhuhai 519000,China;Department of Radiology,Zhuhai Precision Medical Center,Zhuhai People's Hospital,Zhuhai Hospital of Jinan University,Zhuhai 519000,China;Department of Interventional Treatment,Zhongshan City People's Hospital,Zhongshan 528400,China;Department of Radiology,Shenzhen People's Hospital,Shenzhen 518000,China;Interventional Diagnosis and Treatment Department,Nanfang Hospital,Southern Medical University,Guangzhou,510000,China;Department of Radiology,Yangjiang People's Hospital,Yangjiang 529500,China;Beijing Advanced Innovation Center for Big Data-Based Precision Medicine,School of Medicine and Engineering,Beihang University,Beijing 100191,China;Engineering Research Center of Molecular and Neuro Imaging of Ministry of Education,School of Life Science and Technology,Xidian University,Xi'an 710126,China
Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
Shen Junyi;Qi Weili;Dai Junlong;Leng Shusheng;Jiang Kangyi;Zhang Yu;Ran Shun;Li Chuan;Wen Tianfu-Department of Liver Surgery and Liver Transplantation Center, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Laboratory of Liver Transplantation, Frontiers Science Center for Disease-Related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Institute of Clinical Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Department of Hepatobiliary and Pancreatic Surgery, The Affiliated Hospital of Chengdu University, Chengdu, Sichuan 610072, China;Department of Hepatobiliary and Pancreatic Surgery, The People's Hospital of Leshan, Leshan, Sichuan 614700, China;Department of Hepatobiliary Surgery, Sichuan Provincial People's Hospital, Chinese Academy of Sciences, Chengdu, Sichuan 610072, China;Department of Hepatobiliary Surgery, Affiliated Cancer Hospital of Guizhou Medical University, Guiyang, Guizhou 550000, China
Intensive phototherapy vs. exchange transfusion for the treatment of neonatal hyperbilirubinemia: a multicenter retrospective cohort study
Zhang Meng;He Yang;Tang Jun;Dong Wenbin;Zhang Yong;Zhang Benjin;Wan Hong;Deng Quanmin;Guan Lirong;Xia Bin;Chen Zhong;Ge Min;Zhao Jing;Li Wenxing;Pei Jingjun;Qu Yi;Mu Dezhi-Department of Pediatrics, West China Second Hospital, Sichuan University, Chengdu, Sichuan 610041, China;Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, Sichuan 610041, China;Department of Pediatrics, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan 646099, China;Department of Pediatrics, Sichuan Maternal and Child Health Hospital, Chengdu, Sichuan 610045, China;Department of Pediatrics, Dazhou Central Hospital, Dazhou, Sichuan 635000, China;Department of Pediatrics, Leshan Maternal and Child Health Hospital, Leshan, Sichuan 614000, China;Department of Pediatrics, People’s Hospital of Deyang, Deyang, Sichuan 618000, China;Department of Pediatrics, Mianyang Central Hospital, Mianyang, Sichuan 621000, China
A novel chemotherapy strategy for advanced hepatocellular carcinoma: a multicenter retrospective study
Sun Juxian;Liu Chang;Shi Jie;Wang Nanya;Jiang Dafeng;Mao Feifei;Gu Jingwen;Zhou Liping;Shen Li;Yee Lau Wan;Cheng Shuqun-Department of Hepatic Surgery VI, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Integrative Oncology, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Outpatient Department, Eastern Hepatobiliary Surgery Hospital, The Second Military Medical University, Shanghai 200433, China;Department of Oncology, First Hospital of Jilin University, Changchun, Jilin 130000, China;Department of Oncology Zhejiang Sian International Hospital, Jiaxing, Zhejiang 314000, China;Tongji University Cancer Center, Shanghai Tenth People’s Hospital, School of Medicine, Tongji University, Shanghai 200040, China;Faculty of Medicine, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, New Territories, Hong Kong SAR 999077, China
Hepatopancreatoduodenectomy for advanced biliary malignancies
Wu Xiangsong;Li Maolan;Wu Wenguang;Wang Xu’an;Li Huaifeng;Bao Runfa;Shu Yijun;Shen Jun;Gu Jun;Wang Xuefeng;Gong Wei;Peng Shuyou;Liu Yingbin-Department of General Surgery, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China;Shanghai Research Center of Biliary Tract Disease, Shanghai 200092, China;Department of Biliary-Pancreatic Surgery, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China;State Key Laboratory of Oncogenes and Related Genes, Shanghai 200092, China;Department of General Surgery, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejing 310009, China
Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer
Dan Lyu;Binliang Liu;Bo Lan;Xiaoying Sun;Lixi Li;Jingtong Zhai;Haili Qian;Fei Ma-Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Breast Cancer Medical Oncology,Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha 410013,China;Department of Medical Oncology,Cancer Hospital of Huanxing Chaoyang District,Beijing 100122,China;State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer:A real-world,multicenter,retrospective,controlled study in China
Hanxiao Chen;Xiangjuan Ma;Jie Liu;Yu Yang;Yong Fang;Liping Wang;Jian Fang;Jun Zhao;Minglei Zhuo-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅰ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅱ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Pneumology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China;Department of Oncology,the 2nd Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Oncology,Sir Run Run Shaw Hospital Zhejiang University School of Medicine,Hangzhou 310020,China;Department of Oncology,Baotou Cancer Hospital,Baotou 014030,China
Predictors of pathologic complete response in patients with residual flat mucosal lesions after neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Changlong Li;Zhen Guan;Yi Zhao;Tingting Sun;Zhongwu Li;Weihu Wang;Zhexuan Li;Lin Wang;Aiwen Wu-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Gastrointestinal Cancer Center,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Pathology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Radiation Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Cancer Epidemiology,Peking University Cancer Hospital&Institute,Beijing 100142,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。